Elevai's Enfinity serum named Dermatologist's Pick by Harper's Bazaar
The exosome serum was top-ranked in a feature on exosome skincare, selected by dermatologist Dr. Hadley King.
See the latest news and media coverage for Elevai. We track all announcements, press releases, and industry mentions in real time, all in one place.
Skincare and hair care brand using exosomes
elevaiskincare.comLast updated
In short: Elevai achieved widespread media recognition for its exosome serums and underwent a significant corporate acquisition by Carmell.
The exosome serum was top-ranked in a feature on exosome skincare, selected by dermatologist Dr. Hadley King.
Dermatologist Dr. Natalie Curcio recommends it as her favorite twice-daily exosome product, citing benefits for pigmentation, redness, and wrinkles.
The Enfinity serum combines exosomes, peptides, and antioxidants to target eight signs of aging including texture and radiance.
The feature explores exosomes as a promising innovation and notes the serum's formulation including umbilical cord-derived exosomes, vitamin C, and hyaluronic acid.
Elevai Skincare creates products using stem cells to restore damaged skin and hair The skincare subsidiary of former Elevai Labs Inc. has been acquired by...
On September 23, 2024, Altium Capital Management LP (Trades, Portfolio) marked a significant...
Elevai Labs, Inc. (NASDAQ:ELAB) shares are trading higher Tuesday after the company announced it signed an exclusive, worldwide manufacturing and processing technology licensing agreement with...
Elevai Labs Inc. is looking to take its stem cell technology public. The Newport Beach-based regenerative skincare company filed plans with the Securities and Exchange...
Track Elevai and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.
Discover what's making headlines across other trending companies.